HLTHQ.US Cue Health Inc.
- Market cap
- USD 15.9K
- P/E
- -
- P/B
- -
- ROE
- -99.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2024.
Is HLTHQ.US undervalued?
Graham numberThe Graham number of Cue Health Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cue Health Inc. fundamental analysis
No fundamental analysis for Cue Health Inc. yet.
Cue Health Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cue Health Inc.
Cue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. It offers Cue Integrated Care platform comprising hardware, software, and diagnostic components, such as Cue Health Monito…
Full company profileCue Health Inc. financial statements
2024 annualized: Fiscal year 2024 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2024, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cue Health Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 6.63M | 23.0M | 618M | 483M | 64.2M | 40.2M |
| Gross Profit | 6.63M | 8.00M | 342M | 154M | -62.9M | -25.1M |
| Operating Income | -20.8M | -45.1M | 190M | -204M | -395M | -176M |
| EBITDA | -16.8M | -39.5M | 167M | -148M | -311M | -197M |
| Net Income | -20.6M | -47.4M | 33.1M | -194M | -373M | -198M |
| EPS | -0.14 | -0.33 | 0.23 | -1.31 | -2.44 | -1.25 |
| Balance Sheet | ||||||
| Total Assets | 27.4M | 316M | 940M | 695M | 340M | 284M |
| Total Liabilities | 11.8M | 241M | 233M | 118M | 89.5M | 84.2M |
| Shareholders' Equity | 15.6M | 74.9M | 707M | 576M | 250M | 199M |
| Cash & Short-term Investments | 14.3M | 128M | 424M | 242M | 81.7M | 41.0M |
| Total Debt | 7.25M | 19.8M | 59.5M | 55.0M | 47.9M | 44.3M |
| Cash Flow | ||||||
| Operating Cash Flow | -13.1M | 92.5M | -9.45M | -113M | -138M | - |
| Capital Expenditure | 2.95M | 78.1M | 116M | 63.0M | 19.8M | - |
| Free Cash Flow | -16.0M | 14.4M | -125M | -176M | -158M | - |
| Ratios | ||||||
| ROE | -132.4% | -63.2% | 4.7% | -33.7% | -149.2% | -99.3% |
| ROA | -75.3% | -15.0% | 3.5% | -27.9% | -109.9% | -69.8% |
| Net Profit Margin | -311.0% | -206.3% | 5.4% | -40.1% | -581.5% | -492.5% |
| Debt to Equity | 0.47x | 0.26x | 0.08x | 0.10x | 0.19x | 0.22x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Cue Health Inc. dividends
Cue Health Inc. has not paid dividends in the last 5 fiscal years.
Who owns Cue Health Inc.
Ownership data of Cue Health Inc. is not available yet.
Cue Health Inc. company profile
- Company name
- Cue Health Inc.
- Ticker
- HLTHQ.US
- Exchange
- USA Stocks
- Listed since
- Sep 24, 2021
- Sector
- Healthcare
- Industry
- Health Information Services
- Employees
- 726
- Fiscal year end
- December
- Address
- 4980 Carroll Canyon Road, San Diego, CA, United States, 92121
- Phone
- (858) 412-8151
- Website
- cuehealth.com
About Cue Health Inc.
Cue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. It offers Cue Integrated Care platform comprising hardware, software, and diagnostic components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, including integration with electronic medical record system, pharmacies and last-mile delivery, clinician networks, and laboratories. The company also provides COVID-19 testing kits. The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California. On May 28, 2024, Cue Health Inc., along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.
Cue Health Inc. management
5- Mr. Clint SeverCo-Founder & CEO · born 1985
- Mr. Randall E. PollardChief Accounting Officer, Controller & Principal Financial Officer · born 1972
- Ms. Allison F. BlackwellChief Human Resources Officer · born 1965
- Mr. Christopher K. AcharChief Business Officer & Director · born 1985
- Dr. David Tsay M.D., Ph.D.Chief Medical Officer